RETIGABINE

Retigabine is a neuronal potassiumchannel opener used for refractory epilepsy. Side effects include dizziness, somnolence, urinary retention, blurred vision, and rare blueskin or retinal discoloration. Only GMP materials will be supplied, logistics all according to GDP.

SKU: 403af74803f3 Category: Tag:

Product Description


Mechanism of Action

RETIGABINE engages in multilayer biochemical interactions affecting enzyme cascades, receptorregulated signalling, oxidativestress systems, mitochondrial respiration, ionchannel dynamics, cytoskeletal mechanics and transcriptionfactor pathway coordination. Molecularmodelling parameters suggest potential interactions with catalytic centres, allosteric microdomains, transmembrane receptor helices, cofactorbinding regions, and structural scaffolding proteins. These interactions enable modulation of phosphorylation cycles, secondmessenger amplification (Ca²⁺, cAMP, IP, DAG), ATP turnover, mitochondrial membrane potential and ROS balancing capacity.

Benefits and Applications

  • Receptorligand affinity mapping and molecular docking
  • Enzymekinetic pathway modelling and catalyticflux analysis
  • Mitochondrial bioenergetics profiling and redoxstate research
  • Multiomics studies (transcriptomics, metabolomics, proteomics)
  • Cytoskeletal architecture analysis and membranedynamics modelling
  • Apoptosis, necroptosis, autophagy and ferroptosis pathway assays
  • SAR and QSARdriven molecular optimisation
  • Pharmacodynamic and mechanistic doseresponse modelling

Risks & Side Effects

  • Oxidative imbalance and ROS escalation
  • Mitochondrial overload or suppression of respiratory complexes
  • Ionchannel destabilisation (Na⁺/K⁺/Ca²⁺)
  • Unintended receptor crosstalk
  • Cytoskeletal destabilisation
  • Dosedependent cytotoxicity or programmed-cell-death activation
  • Inflammatory transcriptional activation (NF-κB, JNK, MAPK)

Only GMP materials will be supplied, logistics all according to GDP.

Datasheet


Molecular Formula

C16H18FN3O2

Molecular Weight

303.33 g/mol

CAS Number

150812-12-7

Storage Condition

Keep container tightly closed in a dry and well-ventilated place.

Solubility

At room temperature … practically insoluble in aqueous media above pH4, while the solubility is higher in polar organic solvents

Purity

Purity information is available upon request (COA).

Synonym

Retigabine; 150812-12-7; Ezogabine; Potiga; Trobalt

IUPAC/Chemical Name

ethyl N-[2-amino-4-[(4-fluorophenyl)methylamino]phenyl]carbamate

InChl Key

PCOBBVZJEWWZFR-UHFFFAOYSA-N

InChl Code

InChI=1S/C16H18FN3O2/c1-2-22-16(21)20-15-8-7-13(9-14(15)18)19-10-11-3-5-12(17)6-4-11/h3-9,19H,2,10,18H2,1H3,(H,20,21)

References

https://pubchem.ncbi.nlm.nih.gov/compound/121892;

3D Conformer.

(Click, turn or enlarge)

Download our GMP API Product List.

MedicaPharma is an EU-based supplier of GMP-certified APIs that serves leading healthcare institutions and research organizations.
Click here to download our full API product list.

Download